U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 7836

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr2:152394381
GRCh38:
Chr2:151537867
NEBNemaline myopathy 2Uncertain significance
(Jun 28, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr2:152363484-152363485
GRCh38:
Chr2:151506970-151506971
NEB, RIF1T6131fs, T7832fs, T7867fsNemaline myopathy 2Likely pathogeniccriteria provided, single submitter
3.
GRCh37:
Chr2:152487314
GRCh38:
Chr2:151630800
NEBW2970*, W3213*Nemaline myopathy 2Likely pathogeniccriteria provided, single submitter
4.
GRCh37:
Chr2:152527710
GRCh38:
Chr2:151671196
NEBK1445*Nemaline myopathy 2Likely pathogeniccriteria provided, single submitter
5.
GRCh37:
Chr2:152483693
GRCh38:
Chr2:151627179
NEBW3147*, W3390*Nemaline myopathy 2Likely pathogeniccriteria provided, single submitter
6.
GRCh37:
Chr2:152468698
GRCh38:
Chr2:151612184
NEBNemaline myopathy 2Uncertain significance
(May 2, 2023)
criteria provided, single submitter
7.
GRCh37:
Chr2:152472595
GRCh38:
Chr2:151616081
NEBS3494F, S3737FNemaline myopathy 2Uncertain significance
(May 7, 2021)
criteria provided, single submitter
8.
GRCh37:
Chr2:152370925
GRCh38:
Chr2:151514411
RIF1, NEBD5977E, D7678E, D7713ENemaline myopathy 2Uncertain significance
(May 7, 2021)
criteria provided, single submitter
9.
GRCh37:
Chr2:152408343-152408353
GRCh38:
Chr2:151551829-151551839
NEBY4914fs, Y6615fsNemaline myopathy 2Likely pathogenic
(Oct 21, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr2:152357910
GRCh38:
Chr2:151501396
NEB, RIF1S8006G, S8041GNemaline myopathy 2Likely benign
(Oct 23, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr2:152468727
GRCh38:
Chr2:151612213
NEBNemaline myopathy 2Benign
(Mar 19, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr2:152342343
GRCh38:
Chr2:151485829
RIF1, NEBW6647*, W8503*, W8538*Nemaline myopathy 2, not providedUncertain significance
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr2:152394768
GRCh38:
Chr2:151538254
NEBNemaline myopathy 2Likely benign
(Feb 2, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr2:152406218
GRCh38:
Chr2:151549704
NEBG4960R, G6661RNemaline myopathy 2Likely benign
(Oct 20, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr2:152522833
GRCh38:
Chr2:151666319
NEBH1601RNemaline myopathy 2Uncertain significance
(Jun 28, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr2:152499078-152500653
NEBNemaline myopathy 2Pathogenic
(Aug 6, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr2:152470770-152554182
NEBNemaline myopathy 2Pathogenic
(Oct 11, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr2:152417187-152418727
NEBNemaline myopathy 2Pathogenic
(Nov 14, 2021)
criteria provided, single submitter
19.
GRCh37:
Chr2:152466303-152477560
NEBNemaline myopathy 2Uncertain significance
(Dec 13, 2021)
criteria provided, single submitter
20.
GRCh37:
Chr2:152348187-152425896
NEBNemaline myopathy 2Likely pathogenic
(Sep 23, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr2:152506680-152510623
NEBNemaline myopathy 2Pathogenic
(Mar 26, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr2:152579876-152589670
NEBNemaline myopathy 2Pathogenic
(Aug 25, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr2:152369227-152376302
NEBNemaline myopathy 2Uncertain significance
(Dec 19, 2021)
criteria provided, single submitter
24.
GRCh37:
Chr2:152466303-152563531
NEBNemaline myopathy 2Pathogenic
(Aug 25, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr2:152482028-152566297
NEBNemaline myopathy 2Pathogenic
(Nov 2, 2021)
criteria provided, single submitter
26.
GRCh37:
Chr2:152408232-152432888
NEBNemaline myopathy 2Pathogenic
(Aug 25, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr2:152466303-152955525
CACNB4, ARL5A, NEBNemaline myopathy 2Pathogenic
(Mar 9, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr2:152470770-152471121
NEBNemaline myopathy 2Uncertain significance
(Aug 30, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr2:152475955-152476286
NEBNemaline myopathy 2Pathogenic
(Mar 2, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr2:152387634
GRCh38:
Chr2:151531120
RIF1, NEBNemaline myopathy 2Likely benign
(Dec 30, 2021)
criteria provided, single submitter
31.
GRCh37:
Chr2:152492804
GRCh38:
Chr2:151636290
NEBNemaline myopathy 2Likely benign
(Feb 6, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr2:152518775
GRCh38:
Chr2:151662261
NEBNemaline myopathy 2Likely benign
(Aug 6, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr2:152456982
GRCh38:
Chr2:151600468
NEBNemaline myopathy 2Likely benign
(Sep 13, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr2:152354238-152354239
GRCh38:
Chr2:151497724-151497725
NEB, RIF1Nemaline myopathy 2Uncertain significance
(Jul 15, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr2:152370077
GRCh38:
Chr2:151513563
RIF1, NEBNemaline myopathy 2Likely benign
(Jan 8, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr2:152459122
GRCh38:
Chr2:151602608
NEBNemaline myopathy 2Likely benign
(Jan 3, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr2:152346607
GRCh38:
Chr2:151490093
RIF1, NEBNemaline myopathy 2Uncertain significance
(Apr 11, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr2:152420399
GRCh38:
Chr2:151563885
NEBT4472P, T6173PNemaline myopathy 2Uncertain significance
(Sep 27, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr2:152539235
GRCh38:
Chr2:151682721
NEBV962MNemaline myopathy 2Likely benign
(May 22, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr2:152398083
GRCh38:
Chr2:151541569
NEBNemaline myopathy 2Uncertain significance
(Aug 21, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr2:152507239
GRCh38:
Chr2:151650725
NEBS2359TNemaline myopathy 2Likely benign
(Oct 19, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr2:152371408
GRCh38:
Chr2:151514894
RIF1, NEBK5946R, K7647R, K7682RNemaline myopathy 2Likely benign
(Nov 3, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr2:152499862
GRCh38:
Chr2:151643348
NEBL2654Fnot provided, Nemaline myopathy 2Conflicting interpretations of pathogenicity
(Sep 27, 2022)
criteria provided, conflicting interpretations
44.
GRCh37:
Chr2:152346971
GRCh38:
Chr2:151490457
NEB, RIF1Nemaline myopathy 2Benign
(Oct 23, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr2:152406155
GRCh38:
Chr2:151549641
NEBS4981G, S6682GNemaline myopathy 2Uncertain significance
(Aug 6, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr2:152512493
GRCh38:
Chr2:151655979
NEBNemaline myopathy 2Likely benign
(Mar 12, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr2:152465119
GRCh38:
Chr2:151608605
NEBNemaline myopathy 2Likely benign
(Nov 2, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr2:152566189
GRCh38:
Chr2:151709675
NEBA339VNemaline myopathy 2Uncertain significance
(Mar 25, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr2:152383517
GRCh38:
Chr2:151527003
NEB, RIF1R5586Q, R7287Q, R7322QNemaline myopathy 2Likely benign
(Jun 13, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr2:152346471
GRCh38:
Chr2:151489957
NEB, RIF1Nemaline myopathy 2Likely benign
(Oct 21, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr2:152423732
GRCh38:
Chr2:151567218
NEBD4335H, D6036HNemaline myopathy 2Uncertain significance
(Jun 30, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr2:152518732
GRCh38:
Chr2:151662218
NEBH1963YNemaline myopathy 2Likely benign
(Sep 19, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr2:152348947
GRCh38:
Chr2:151492433
RIF1, NEBT6420N, T8276N, T8311NNemaline myopathy 2Likely benign
(Jul 25, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr2:152457244
GRCh38:
Chr2:151600730
NEBNemaline myopathy 2Likely benign
(Jul 1, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr2:152586135
GRCh38:
Chr2:151729621
NEBNemaline myopathy 2Likely benign
(Jun 1, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr2:152370854
GRCh38:
Chr2:151514340
RIF1, NEBN6001S, N7702S, N7737SNemaline myopathy 2Likely benign
(Sep 9, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr2:152404846
GRCh38:
Chr2:151548332
NEBNemaline myopathy 2Likely benign
(Mar 18, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr2:152502657
GRCh38:
Chr2:151646143
NEBI2508TNemaline myopathy 2Uncertain significance
(Jul 6, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr2:152346503
GRCh38:
Chr2:151489989
NEB, RIF1Nemaline myopathy 2Likely benign
(May 27, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr2:152541418
GRCh38:
Chr2:151684904
NEBNemaline myopathy 2Likely benign
(Jul 23, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr2:152534483
GRCh38:
Chr2:151677969
NEBN1158KNemaline myopathy 2Uncertain significance
(Aug 1, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr2:152426856
GRCh38:
Chr2:151570342
NEBNemaline myopathy 2Likely benign
(Apr 20, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr2:152370162
GRCh38:
Chr2:151513648
RIF1, NEBL6024V, L7725V, L7760VNemaline myopathy 2Likely benign
(Mar 3, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr2:152553672
GRCh38:
Chr2:151697158
NEBQ487LNemaline myopathy 2Likely benign
(May 16, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr2:152382541
GRCh38:
Chr2:151526027
NEB, RIF1Nemaline myopathy 2Likely benign
(Aug 4, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr2:152534237
GRCh38:
Chr2:151677723
NEBI1206VNemaline myopathy 2Uncertain significance
(Aug 5, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr2:152574014
GRCh38:
Chr2:151717500
NEBNemaline myopathy 2Likely benign
(Oct 29, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr2:152461218
GRCh38:
Chr2:151604704
NEBNemaline myopathy 2Likely benign
(Oct 4, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr2:152467079
GRCh38:
Chr2:151610565
NEBD3747A, D3990ANemaline myopathy 2Likely pathogenic
(Jan 20, 2023)
no assertion criteria provided
70.
GRCh37:
Chr2:152496563
GRCh38:
Chr2:151640049
NEBK2899fsNemaline myopathy 2Likely pathogenic
(Jan 25, 2023)
criteria provided, single submitter
71.
GRCh37:
Chr2:152397279
GRCh38:
Chr2:151540765
NEBH5206fs, H6907fsNemaline myopathy 2Pathogenic
(Jan 25, 2023)
criteria provided, single submitter
72.
GRCh37:
Chr2:152404857
GRCh38:
Chr2:151548343
NEBV6708I, V5007INemaline myopathy 2Uncertain significance
(Jan 25, 2023)
criteria provided, single submitter
73.
GRCh37:
Chr2:152499734
GRCh38:
Chr2:151643220
NEBF2697SInborn genetic diseases, Nemaline myopathy 2Conflicting interpretations of pathogenicity
(Oct 28, 2022)
criteria provided, conflicting interpretations
74.
GRCh37:
Chr2:152521899
GRCh38:
Chr2:151665385
NEBM1729TNemaline myopathy 2Likely benign
(Jul 7, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr2:152548824
GRCh38:
Chr2:151692310
NEBC650YNemaline myopathy 2Uncertain significance
(May 27, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr2:152487787
GRCh38:
Chr2:151631273
NEBK3163Rnot provided, Nemaline myopathy 2Uncertain significance
(Jul 29, 2022)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr2:152531863
GRCh38:
Chr2:151675349
NEBT1273Anot provided, Nemaline myopathy 2Conflicting interpretations of pathogenicity
(Nov 3, 2022)
criteria provided, conflicting interpretations
78.
GRCh37:
Chr2:152404157
GRCh38:
Chr2:151547643
NEBV5051fs, V6752fsNemaline myopathy 2Pathogenic
(May 2, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr2:152394723
GRCh38:
Chr2:151538209
NEBNemaline myopathy 2Uncertain significance
(Jun 19, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr2:152346955
GRCh38:
Chr2:151490441
RIF1, NEBE8410K, E8445K, E6554KNemaline myopathy 2Likely benign
(Sep 3, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr2:152342287
GRCh38:
Chr2:151485773
RIF1, NEBV8557A, V6666A, V8522ANemaline myopathy 2, Inborn genetic diseasesConflicting interpretations of pathogenicity
(Feb 6, 2023)
criteria provided, conflicting interpretations
82.
GRCh37:
Chr2:152553238
GRCh38:
Chr2:151696724
NEBK494NNemaline myopathy 2Likely benign
(Oct 14, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr2:152528997
GRCh38:
Chr2:151672483
NEBM1395INemaline myopathy 2, not providedUncertain significance
(Sep 17, 2021)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr2:152492766
GRCh38:
Chr2:151636252
NEBK3026RNemaline myopathy 2, not providedUncertain significance
(Sep 17, 2021)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr2:152403945
GRCh38:
Chr2:151547431
NEBD5088N, D6789NNemaline myopathy 2, not providedConflicting interpretations of pathogenicity
(Oct 18, 2022)
criteria provided, conflicting interpretations
86.
GRCh37:
Chr2:152349856
GRCh38:
Chr2:151493342
RIF1, NEBNemaline myopathy 2Likely benign
(Oct 5, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr2:152487733
GRCh38:
Chr2:151631219
NEBD3181GNemaline myopathy 2Uncertain significance
(Aug 12, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr2:152554055
GRCh38:
Chr2:151697541
NEBNemaline myopathy 2Uncertain significance
(May 3, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr2:152382499
GRCh38:
Chr2:151525985
NEB, RIF1Nemaline myopathy 2Benign
(Apr 18, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr2:152527659
GRCh38:
Chr2:151671145
NEBK1462ENemaline myopathy 2, not providedConflicting interpretations of pathogenicity
(May 13, 2022)
criteria provided, conflicting interpretations
91.
GRCh37:
Chr2:152474884
GRCh38:
Chr2:151618370
NEBI3661F, I3418FNemaline myopathy 2Likely benign
(May 5, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr2:152512320
GRCh38:
Chr2:151655806
NEBNemaline myopathy 2Likely benign
(Jan 20, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr2:152544837
GRCh38:
Chr2:151688323
NEBQ795RNemaline myopathy 2Uncertain significance
(May 11, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr2:152563380
GRCh38:
Chr2:151706866
NEBNemaline myopathy 2Uncertain significance
(Sep 19, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr2:152566265
GRCh38:
Chr2:151709751
NEBE314KNemaline myopathy 2Likely benign
(May 1, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr2:152511837
GRCh38:
Chr2:151655323
NEBP2252SNemaline myopathy 2, not providedConflicting interpretations of pathogenicity
(Sep 12, 2022)
criteria provided, conflicting interpretations
97.
GRCh37:
Chr2:152390749
GRCh38:
Chr2:151534235
RIF1, NEBA5432T, A7133TInborn genetic diseases, Nemaline myopathy 2Conflicting interpretations of pathogenicity
(Oct 26, 2022)
criteria provided, conflicting interpretations
98.
GRCh37:
Chr2:152484136
GRCh38:
Chr2:151627622
NEBNemaline myopathy 2Likely benign
(Apr 21, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr2:152404896
GRCh38:
Chr2:151548382
NEBA4994P, A6695PNemaline myopathy 2Likely benign
(Sep 28, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr2:152520319
GRCh38:
Chr2:151663805
NEBS1836GNemaline myopathy 2Likely benign
(Sep 14, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination